1.21. Analysis.

Comparison 1 ICS versus placebo, parallel‐group studies, greater than 6 months (all doses), Outcome 21 Any fractures (no. of patients).

Comparison 1 ICS versus placebo, parallel‐group studies, greater than 6 months (all doses), Outcome 21 Any fractures (no. of patients).